SCHEMBL2534969

SCHEMBL2534969

CC(C)C(C)(C=O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C19 P33261 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.39
▸ ESR1 P03372 2/20 0.39
▸ ESR2 Q92731 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ MAPK1 P28482 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ TP53 P04637 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ TAAR1 Q96RJ0 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ RIPK1 Q13546 1/20 0.35
▸ HDAC3 O15379 1/20 0.35
▸ HDAC4 P56524 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC7 Q8WUI4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28653244 0.80 KIF11 (0.41) CYP1A2CYP2D6CYP2C19HIF1AALDH1A1
SCHEMBL27081757 0.80 NR3C2 (0.35) CYP1A2CYP2D6CYP2C19HIF1AALDH1A1
SCHEMBL28953183 0.76 KEAP1 (0.39) ALDH1A1KMT2ATSHRMEN1LMNA
SCHEMBL27452194 0.76 CYP2D6 (0.44) CYP1A2CYP2D6CYP2C19HIF1AALDH1A1
SCHEMBL9252948 0.74 CYP2D6 (0.39) CYP1A2CYP2D6CYP2C19HIF1AALDH1A1
SCHEMBL10838422 0.72 CYP2D6 (0.46) CYP1A2CYP2D6CYP2C19HIF1AALDH1A1
SCHEMBL10839537 0.72 CYP2D6 (0.46) CYP1A2CYP2D6CYP2C19HIF1AALDH1A1
SCHEMBL10838417 0.72 CYP2D6 (0.46) CYP1A2CYP2D6CYP2C19HIF1AALDH1A1
SCHEMBL2121346 0.72 ESR1 (0.44) CYP2C19HIF1AALDH1A1ESR1ESR2
SCHEMBL28102219 0.72 ALDH1A1 (0.44) CYP2C19HIF1AALDH1A1ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109400438-B Synthesis method of 9, 10-disubstituted phenanthrene compound 西北大学 2021-07-02 — — CN claimed
CN-109400438-B Synthesis method of 9, 10-disubstituted phenanthrene compound 西北大学 2021-07-02 — — CN disclosed
CN-109400438-A One kind 9,10- bis- replaces the synthetic method of luxuriant and rich with fragrance class compound 西北大学 2019-03-01 — — CN disclosed
WO-2015034478-A1 SCALE-INHIBITING COCRYSTALS FOR TREATMENT OF A SUBTERRANEAN FORMATION HALLIBURTON ENERGY SERVICES, INC. (US) 2015-03-12 — — WO disclosed
WO-2015030730-A1 ENERGETIC COCRYSTALS FOR TREATMENT OF A SUBTERRANEAN FORMATION HALLIBURTON ENERGY SERVICES, INC. (US) 2015-03-05 — — WO disclosed
US-8350085-B2 Cocrystallization NEW FORM PHARMACEUTICALS INC. (US) 2013-01-08 — — US disclosed
US-8212079-B2 Cocrystallization APTUIT (WEST LAFAYETTE), LLC (US) 2012-07-03 — — US disclosed
US-20110257430-A1 NOVEL COCRYSTALLIZATION APTUIT (KANSAS CITY), LLC (US) 2011-10-20 — — US disclosed
US-20090281195-A1 NOVEL COCRYSTALLIZATION S.S.C.I., INC. (US) 2009-11-12 — — US disclosed
US-7452555-B2 Cocrystallization S.S.C.I., INC. (US) 2008-11-18 — — US disclosed
US-20070287194-A1 Screening For Solid Forms By Ultrasound Crystallization And Cocrystallization Using Ultrasound S.S.C.I., INC 2007-12-13 — — US disclosed
US-20070088508-A1 Cocrystallization methods APTUIT (WEST LAFAYETTE), LLC 2007-04-19 — — US disclosed
Send feedback